Cargando…

Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489569/ https://www.ncbi.nlm.nih.gov/pubmed/31114179 http://dx.doi.org/10.2147/COPD.S208588

Ejemplares similares

Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status
por: Fireman Klein, Einat, et al.
Publicado: (2019)

The Relationship Between Morning Symptoms and the Risk of Future Exacerbations in COPD [Corrigendum]
Publicado: (2021)

COPD management costs according to the frequency of COPD exacerbations in UK primary care [Corrigendum]
Publicado: (2014)

Nasal high-flow in acute hypercapnic exacerbation of COPD [Corrigendum]
Publicado: (2019)

Repetitive Saliva Swallowing Test Predicts COPD Exacerbation [Corrigendum]
Publicado: (2021)

Predicting frequent COPD exacerbations using primary care data [Corrigendum]
Publicado: (2018)

The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia [Corrigendum]
Publicado: (2016)

The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset [Corrigendum]
Publicado: (2022)

Low Eosinophil Phenotype Predicts Noninvasive Mechanical Ventilation Use in Patients with Hospitalized Exacerbations of COPD [Corrigendum]
Publicado: (2022)

Sinonasal Symptoms in COPD: Burden and Associations with Clinical Markers of Disease [Corrigendum]
Publicado: (2022)

Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD [Corrigendum]
Publicado: (2020)

Comparison of the clinical characteristics and treatment outcomes of patients requiring hospital admission to treat eosinophilic and neutrophilic exacerbations of COPD [Corrigendum]
Publicado: (2017)

Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone [Corrigendum]
Publicado: (2022)

Corrigendum to “Hematological Inflammatory Markers in Patients with Clinically Confirmed Familial Hypercholesterolemia”
por: Vaseghi, Golnaz, et al.
Publicado: (2023)

Corrigendum to “Recommendations for Diagnosis and Management of Osteoporosis in COPD Men”
por: Mazokopakis, Elias E., et al.
Publicado: (2017)

Development of an integral assessment approach of health status in patients with obstructive airway diseases: the CORONA study [Corrigendum]
Publicado: (2016)

Sam68 is a novel marker for aggressive neuroblastoma [Corrigendum]
Publicado: (2014)

Extraglottic airway devices: technology update [Corrigendum]
Publicado: (2018)

Bronchiectasis in COPD patients: more than a comorbidity? [Corrigendum]
Publicado: (2019)

Russian guidelines for the management of COPD: algorithm of pharmacologic treatment [Corrigendum]
Publicado: (2019)

The Short Physical Performance Battery is a discriminative tool for identifying patients with COPD at risk of disability [Corrigendum]
Publicado: (2016)

Corrigendum to “Single Bout Exercise in Children with Juvenile Idiopathic Arthritis: Impact on Inflammatory Markers”
por: Rochette, Emmanuelle, et al.
Publicado: (2018)

Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD [Corrigendum]
Publicado: (2014)

Image-Enhanced Bronchoscopic Evaluation of Bronchial Mucosal Microvasculature in COPD [Corrigendum]
Publicado: (2022)

Novel Intraoral Negative Airway Pressure in Drug-Induced Sleep Endoscopy with Target-Controlled Infusion [Corrigendum]
Publicado: (2022)

Reduced Variability of Endurance Time in New Protocols for Exercise Tests in COPD [Corrigendum]
Publicado: (2021)

The Association Between Cognitive Functions and Psychological Factors in Patients with Severe COPD [Corrigendum]
Publicado: (2023)

Corrigendum: IRB Approval Number Correction. Cardiac Dysfunction in Association with Increased Inflammatory Markers in Primary Aldosteronism
por: Lim, Jung Soo, et al.
Publicado: (2020)

Corrigendum to “Fully Covered Metallic Stents for the Treatment of Benign Airway Stenosis”
por: Dahlqvist, Caroline, et al.
Publicado: (2018)

Corrigendum to: Development and Characterization of Novel Polymorphic Microsatellite Markers for Tapinoma indicum (Hymenoptera: Formicidae)
por: Lim, Li Yang, et al.
Publicado: (2021)

Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry [Corrigendum]
Publicado: (2021)

Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study [Corrigendum]
Publicado: (2020)

Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study [Corrigendum]
Publicado: (2018)

Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey [Corrigendum]
Publicado: (2017)

Corrigendum to “Assessment of Dietary Patterns Represents a Potential, Yet Variable, Measure of Inflammatory Status: A Review and Update”
por: Calle, Mariana C., et al.
Publicado: (2019)

The airway microbiota and exacerbations of COPD
por: Leiten, Elise Orvedal, et al.
Publicado: (2020)

The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis [Corrigendum]
Publicado: (2018)

Corrigendum to “A Case of Severe Acute Kidney Injury Exacerbated by Canagliflozin in a Patient with Type 2 Diabetes”
por: Hassani-Ardakani, Kimya, et al.
Publicado: (2021)

Corrigendum to “Mitochondrial (Dys) Function in Inflammaging: Do MitomiRs Influence the Energetic, Oxidative, and Inflammatory Status of Senescent Cells?”
por: Giuliani, Angelica, et al.
Publicado: (2019)

Blood cell for the differentiation of airway inflammatory phenotypes in COPD exacerbations
por: Gao, Jie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k3ejcuprqnecolj0l6dp5sh8rm